» Articles » PMID: 20816549

Role of Viral Respiratory Infections in Asthma and Asthma Exacerbations

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2010 Sep 7
PMID 20816549
Citations 350
Authors
Affiliations
Soon will be listed here.
Abstract

Viral respiratory tract infections are common and usually selflimited illnesses. For patients at risk of asthma, or with existing asthma, viral respiratory tract infections can have a profound effect on the expression of disease or loss of control. New evidence has shown that wheezing episodes early in life due to human rhinoviruses are a major risk factor for the later diagnosis of asthma at age 6 years. For those with existing asthma, exacerbations are a major cause of morbidity, can need acute care, and can, albeit rarely, result in death. Viral respiratory tract infections, predominantly those caused by human rhinoviruses, are associated with asthma exacerbations. There is also evidence that deficiencies in antiviral activity and the integrity of the airway epithelial barrier could make individuals with asthma more likely to have severe viral respiratory infections of the lower airway, and thus increase the risk of exacerbation. In view of the effect of respiratory viruses on many aspects of asthma, efforts to understand the mechanisms and risk factors by which these airway infections cause changes in airway pathophysiology are a first step towards improved treatment.

Citing Articles

Exploring Asthma as a Protective Factor in COVID-19 Outcomes.

Quinn A, Zhao L, Bell S, Huq M, Fang Y Int J Mol Sci. 2025; 26(4).

PMID: 40004141 PMC: 11855143. DOI: 10.3390/ijms26041678.


Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children.

Moore C, Thornburg J, Secor E, Hamlington K, Schiltz A, Freeman K Respir Res. 2025; 26(1):40.

PMID: 39871239 PMC: 11773965. DOI: 10.1186/s12931-025-03114-y.


Non-Pharmaceutical Interventions May Attenuate Acute Exacerbations of Asthma: Experience During the COVID-19 Pandemic in Taiwan.

Lin C, Lin C, Lo Y, Lo C, Huang H, Hsieh M J Asthma Allergy. 2025; 18:59-67.

PMID: 39867642 PMC: 11760758. DOI: 10.2147/JAA.S488352.


The Role of Inflammation in the Pathogenesis of Viral Respiratory Infections.

Kombe Kombe A, Fotoohabadi L, Gerasimova Y, Nanduri R, Lama Tamang P, Kandala M Microorganisms. 2025; 12(12.

PMID: 39770727 PMC: 11678694. DOI: 10.3390/microorganisms12122526.


A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.

Branche A, Ramesh M, Francis B Infect Dis Ther. 2024; 14(Suppl 1):39-61.

PMID: 39739198 PMC: 11724830. DOI: 10.1007/s40121-024-01081-3.


References
1.
Sakamoto M, Ida S, Takishima T . Effect of influenza virus infection on allergic sensitization to aerosolized ovalbumin in mice. J Immunol. 1984; 132(5):2614-7. View

2.
Parry D, Busse W, Sukow K, Dick C, Swenson C, Gern J . Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000; 105(4):692-8. DOI: 10.1067/mai.2000.104785. View

3.
Ober C, Tan Z, Sun Y, Possick J, Pan L, Nicolae R . Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med. 2008; 358(16):1682-91. PMC: 2629486. DOI: 10.1056/NEJMoa0708801. View

4.
von Mutius E, Radon K . Living on a farm: impact on asthma induction and clinical course. Immunol Allergy Clin North Am. 2008; 28(3):631-47, ix-x. DOI: 10.1016/j.iac.2008.03.010. View

5.
Wos M, Sanak M, Soja J, Olechnowicz H, Busse W, Szczeklik A . The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med. 2008; 177(10):1082-9. PMC: 2383991. DOI: 10.1164/rccm.200607-973OC. View